Literature DB >> 14607350

Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia.

M Partinen1, K Hirvonen, C Hublin, M Halavaara, H Hiltunen.   

Abstract

BACKGROUND: Occasionally, insomniac patients may take a sleeping pill after midnight. This may have consequences on their ability to drive a car and result in an increased risk of car accidents.
METHODS: This double-blind, randomized, placebo-controlled, three-treatment three-period cross-over study investigated the effects of two frequently prescribed hypnotics of different classes in a real life condition on driving performance and psychomotor skills in insomniac women. Single doses of zolpidem 10 mg (Z), temazepam 20 mg (T) or placebo (P) were administered at 2:00 a.m. to 19 women aged 35-60 years in three treatment periods separated by wash-out periods of 3-14 days. After polysomnography at baseline and each treatment night, patients underwent, 5.5 h after drug intake at 7:30 a.m. on the next morning, a STISIM driving simulator test, and a subsequent neuropsychological test (FePsy).
RESULTS: Eighteen insomniac women were included in the analysis (mean age 50 years, mean weight 69 kg, mean BMI 25.6 kg/m2). There were no differences between treatments for the primary outcome measure (mean time to collision; baseline: 0.120 s, P: 0.124, T: 0.118, Z: 0.124; P> or =0.12 for all pairwise comparisons). No differences were recorded for speed deviation and reaction time to tasks for the verum treatments, however, lane position deviation was greater after administration of zolpidem in comparison to both placebo and temazepam (P=0.025 and 0.05, respectively). There were no differences between treatments in the FePsy test. Both medications were well tolerated.
CONCLUSIONS: 5.5 h after drug administration there were no major differences in psychomotor performances between both zolpidem and temazepam compared to placebo, which indicates the absence of significant residual effects at that time. However, certain patients were more susceptible than others to the drug effects (two patients with high number of collisions). This underlines the necessity to strongly advocate against the late intake of hypnotics if patients intend to drive a car early the next morning.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607350     DOI: 10.1016/j.sleep.2003.06.005

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  13 in total

1.  Sedative Hypnotic Medication Use and the Risk of Motor Vehicle Crash.

Authors:  Ryan N Hansen; Denise M Boudreau; Beth E Ebel; David C Grossman; Sean D Sullivan
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

2.  Effect of γ-hydroxybutyrate (GHB) on driving as measured by a driving simulator.

Authors:  Evangelia Liakoni; Delia A Dempsey; Matthew Meyers; Nancy G Murphy; Dary Fiorentino; Christopher Havel; Christine Haller; Neal L Benowitz
Journal:  Psychopharmacology (Berl)       Date:  2018-09-19       Impact factor: 4.530

Review 3.  Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.

Authors:  Tharaka Dassanayake; Patricia Michie; Gregory Carter; Alison Jones
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

4.  Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case series.

Authors:  J Steven Poceta
Journal:  J Clin Sleep Med       Date:  2011-12-15       Impact factor: 4.062

Review 5.  Gene translocations in musculoskeletal neoplasms.

Authors:  Balaji Krishnan; Gaurav Khanna; Denis Clohisy
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

Review 6.  In the Zzz zone: the effects of Z-drugs on human performance and driving.

Authors:  Naren Gunja
Journal:  J Med Toxicol       Date:  2013-06

Review 7.  Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.

Authors:  Toni M Rudisill; Motao Zhu; George A Kelley; Courtney Pilkerton; Brandon R Rudisill
Journal:  Accid Anal Prev       Date:  2016-08-29

8.  Effect of ivabradine, a novel antianginal agent, on driving performance: A randomized, double-blind, placebo-controlled trial in healthy volunteers.

Authors:  Jean-Paul Macher; Samuel Lévy
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 9.  Impact of psychotropic medications on simulated driving: a critical review.

Authors:  Mark J Rapoport; Melanie C Baniña
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.

Authors:  Thomas Roth; David Mayleben; Bruce C Corser; Nikhilesh N Singh
Journal:  Hum Psychopharmacol       Date:  2008-01       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.